Early Phase 1 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have cancer of the esophagus or stomach (including cases that cannot be surgically removed) that has not spread to other parts of the body
- People who have not yet received any treatment for this cancer
- People whose cancer has been confirmed by a laboratory test to be a specific type called adenocarcinoma, and whose cancer has a specific genetic change called an ARID1a mutation, detected through either a blood test or a tissue sample test
- People whose cancer has been tested and shown to be "MSI-Stable" or "pMMR" — meaning it has a particular genetic profile (confirm with trial site for what this means for eligibility)
- People aged 18 or older
- People who weigh more than 66 pounds (approximately 30 kg)
- People who are reasonably active and able to care for themselves, based on a standard medical scoring system called ECOG, with a score of 2 or less (confirm with trial site)
- People for whom it is medically possible to have a repeat biopsy (a procedure to take a small tissue sample)
- People who do not have a significant autoimmune disease (a condition where the immune system mistakenly attacks the body)
Who may not be able to join:
- People whose cancer has already spread to other parts of the body (metastatic disease)
- People who have previously received any systemic treatment (such as chemotherapy or other medicines that work throughout the body) for esophagus, stomach, or gastroesophageal junction cancer
- People who have an autoimmune disease that is not well controlled, as determined by the trial doctor
- People who are unable or unwilling to undergo biopsy procedures to provide tissue samples for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Farshid Dayyani, Chao Family Comprehensive Cancer Center
Phone: 1-877-827-8839
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Subjects Completing Study Treatment; Percentage of Subjects Completing Post-Treatment Biopsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.